SCHEMBL6510135

SCHEMBL6510135

COc1ccc(Sc2cc(Nc3cccc(F)c3)nc(N[C@@H](CC(C)C)C(=O)NCCSC)n2)cc1

nearest known ligand 0.44

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CTSK P43235 12/20 0.44
CTSS P25774 11/20 0.39
CTSL P07711 9/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6510161 0.91 CTSK (0.44) CTSKCTSSCTSL
SCHEMBL6513831 0.90 CTSK (0.44) CTSKCTSSCTSL
SCHEMBL6506223 0.90 CTSK (0.42) CTSKCTSSCTSL
SCHEMBL6512174 0.88 CTSK (0.40) CTSK
SCHEMBL6512111 0.88 CTSK (0.38) CTSK
SCHEMBL6512117 0.88 CTSK (0.38) CTSK
SCHEMBL6512168 0.88 CTSK (0.40) CTSK
SCHEMBL6527852 0.88 CTSK (0.40) CTSKCTSSCTSL
SCHEMBL6513016 0.87 CTSK (0.43) CTSKCTSSCTSL
SCHEMBL6509302 0.87 PDPK1 (0.41) CTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005003103-A2 2, 4, 6-TRI-SUBSTITUTED 6-MEMBERED HETEROCYCLES AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES ASTRAZENECA AB (SE) 2005-01-13 WO claimed
WO-2005003103-A2 2, 4, 6-TRI-SUBSTITUTED 6-MEMBERED HETEROCYCLES AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES ASTRAZENECA AB (SE) 2005-01-13 WO disclosed